Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon Nov 09, 2021 4:03pm

255 Views

Post# 34106598

CEO share buy ...

He's quite the accumulator !

Filed 2021-11-09 14:38 Tx date 2021-11-09	$PRN Profound Medical Corp. (formerly Mira IV Acquisition Corp.)	Menawat, Dr., Arun 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$100,387 +8,100 vol $12.39 each